» Articles » PMID: 39271273

Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making

Overview
Specialties Oncology
Radiology
Date 2024 Sep 13
PMID 39271273
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy aims to achieve a high tumor control probability while minimizing damage to normal tissues. Personalizing radiotherapy treatments for individual patients, therefore, depends on integrating physical treatment planning with predictive models of tumor control and normal tissue complications. Predictive models could be improved using a wide range of rich data sources, including tumor and normal tissue genomics, radiomics, and dosiomics. Deep learning will drive improvements in classifying normal tissue tolerance, predicting intra-treatment tumor changes, tracking accumulated dose distributions, and quantifying the tumor response to radiotherapy based on imaging. Mechanistic patient-specific computer simulations ('digital twins') could also be used to guide adaptive radiotherapy. Overall, we are entering an era where improved modeling methods will allow the use of newly available data sources to better guide radiotherapy treatments.

References
1.
Dudas D, Saghand P, Dilling T, Perez B, Rosenberg S, El Naqa I . Deep Learning-Guided Dosimetry for Mitigating Local Failure of Patients With Non-Small Cell Lung Cancer Receiving Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023; 119(3):990-1000. DOI: 10.1016/j.ijrobp.2023.11.059. View

2.
Gregoire V, Mackie T . State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer Radiother. 2011; 15(6-7):555-9. DOI: 10.1016/j.canrad.2011.04.003. View

3.
Mayo C, Feng M, Brock K, Kudner R, Balter P, Buchsbaum J . Operational Ontology for Oncology (O3): A Professional Society-Based, Multistakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data From Patients Treated for Cancer. Int J Radiat Oncol Biol Phys. 2023; 117(3):533-550. PMC: 10741247. DOI: 10.1016/j.ijrobp.2023.05.033. View

4.
Palma G, Monti S, Cella L . Voxel-based analysis in radiation oncology: A methodological cookbook. Phys Med. 2020; 69:192-204. DOI: 10.1016/j.ejmp.2019.12.013. View

5.
Cousin F, Louis T, Dheur S, Aboubakar F, Ghaye B, Occhipinti M . Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers (Basel). 2023; 15(7). PMC: 10093736. DOI: 10.3390/cancers15071968. View